Egrifta SV (2 mg vial) and Egrifta WR (11.6 mg weekly-reconstitution vial) are the current commercial products
Reach out to us anytime by emailing [email protected] or calling 561-235-0100 , and our friendly support staff will walk you through your questions with clear, personalized answers
For primary research protocols, reconstitute a new vial and refrigerate within 5 minutes of mixing
DsbA-L interacts with catalase to reduce cellular oxidative stress, apoptosis, and renal tubular damage via improving peroxisomal function in HFD/STZ-induced diabetic mice (72)
Through this interaction, TB-500 affects cytoskeletal organization and cellular motility pathways [4]
By binding to specific receptors, VIP promotes bronchodilation, which expands the airways and decreases airway resistance, thereby allowing for improved airflow (8)